Belgium · 
Who invested in ActoGeniX?
ActoGeniX's investors include Ventech, Gimv, EQT life science, Aescap and Baekeland Funds, and 1 more on record.
2008
$26MVenture$4.2MGrantBelgium · Funded startup
Who invested in ActoGeniX
2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$30Mraised across 2 rounds since 2007, from 2 sources
$26MVenture$4.2MGrant
- Latest round
- Grant, $4.2MJul 2007
- Biggest round
- $26MVenture · Feb 2007
- Investors
- 6
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $26M Feb 2007
- Biggest round
- $26M Venture · Feb 2007
- Between rounds
- 5 months from the last two
The rounds
- Jul 2007Grant$4.2M
No investor was named in the report.
From a historical funding record
- Feb 2007Venture$26M6 new
From a historical funding record
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
The exit
ExitBuyerPriceWhen
AcquiredIntrexon Corporation$60MFeb 2015
From historical deal records. Wrong? Tell us.
Everyone who backed them
Baekeland FundsVC firm1round
Biotech Fund FlandersVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about ActoGeniX
How much has ActoGeniX raised?
ActoGeniX has raised $30M across 2 rounds since 2007.
When did ActoGeniX last raise?
ActoGeniX's most recent round was a Grant of $4.2M in Jul 2007.
What was ActoGeniX's biggest round?
ActoGeniX's largest round on record is $26M (Venture), in Feb 2007.
Who backed ActoGeniX first?
ActoGeniX's first round on record, in Feb 2007, was backed by Ventech, Gimv and EQT life science and 3 others.
What stage is ActoGeniX at?
ActoGeniX's latest named round is a Grant, in Jul 2007.
Where is ActoGeniX based?
ActoGeniX is based in Belgium.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.